Navigation Links
Cellular Biomedicine Group Announces Enrollment Milestone for Phase I Clinical Trial for Liver Cancer
Date:5/22/2013

PALO ALTO, Calif., May 22, 2013 /PRNewswire/ -- Cellular Biomedicine Group (OTCQB: CBMG) today announced that it has achieved half of the enrollment of the total projected enrollment required for its Phase I trial to evaluate the safety and preliminary efficacy of TC-DC (Tumor Stem Cell Specific Dendritic Cell) therapy for hepatocellular carcinoma (HCC), the most common type of liver cancer. To date the trial has had no Severe Adverse Effect (SAE) reported.

The Phase I clinical trial for TC-DC therapy for HCC, registered with NIH under number NCT01828762 (click here to view) is an open label clinical trial conducted with Shanghai's PLA 85 Hospital, one of the Liver Disease Centers of People's Liberation Army. The trial will evaluate the safety and efficacy in lowering the incidence of tumor recurrence and metastasis by means of autologous immune cell therapy in primary HCC patients following standard tumor resection and TACE chemotherapy.

Cellular Biomedicine Group's VP and GM of the Autologous Products Business Unit, Cheng Xiang (Chase) Dai, MD, commented, "We expect that enrollment will progress quickly and this study is on schedule to complete Phase I clinical trials."

Hepatocellular Carcinoma
Forty-five percent of the world's HCC patients are in China, with over 300,000 new patients diagnosed every year. Currently the therapies commonly offered to most patients are surgery and local chemotherapy, with a 2-year recurrence rate of 51% and median survival time of 13 months.

The TC-DC therapy that CBMG is developing has had extraordinary US phase II metastatic melanoma trial results, with a 5 year overall survival of 54% in the TC-DC group versus 10% in the control group, and a median survival time of 4.5 years for the TC-DC group, versus 1.3 years for the control group with standard therapies.'/>"/>

SOURCE Cellular Biomedicine Group
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Cellular Dynamics Launches MyCell™ Services
2. Life Technologies and Cellular Dynamics International Partner for Global Commercialization of Novel Stem Cell Technologies
3. CeeTox and Cellular Dynamics Collaborate to Offer Predictive In Vitro Test for Cardiotoxicity Using Human iPSC-derived Cells
4. EastBridge Investment Group Announces Merger with Cellular Biomedicine Group
5. The Treatment Landscape for Hepatocellular Carcinoma Will Change Dramatically Over the Next Ten Years Due to the Launch of New Therapies in the United States and EU5
6. Arteriocyte Receives FDA Approval to Initiate Cellular Therapy Trial for Treatment of Thermal Burn Wounds in Wounded Warriors
7. Intra-Cellular Therapies Announces Completion of Phase I Single Rising Dose Trial of First-in-Class Selective Phosphodiesterase 1 (PDE1) Inhibitor and Reports Top-line Safety and Pharmacokinetic Findings
8. Cellular Dynamics Announces Presentations at the Society of Toxicologys 52nd Annual Meeting Demonstrating the Expanding Impact of iPSC-Derived Human Cells on Toxicology Assay Development
9. Cellular Biomedicine Group Marks the Launch of China Clinical Trial for TC-DC Therapy for Hepatocellular Carcinoma
10. Cellular Dynamics International Opens Facility in California, Leasing Space from the Buck Institute to Derive and Bank Human Induced Pluripotent Stem Cells
11. Exosome Diagnostics Presents Data Demonstrating Clinical Applications of Exosome Technology in Brain Cancer, Prostate Cancer, and Alzheimers Disease at the International Society for Extracellular Vesicles 2013 Annual Meeting
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/2/2014)...  On July 31, the Food and Drug Administration ... moving forward to regulate laboratory-developed tests (LDTs). The clock ... the U.S. will need to comply with a host ... may subscribe to the strategy to simply sit back ... place, it,s widely acknowledged that failure to answer key ...
(Date:9/2/2014)... Sept. 2, 2014 Reportlinker.com announces that a ... Asia - Pacific Minimally Invasive Surgery ... The growth rate of the ... will remain at double-digit levels throughout the forecast period. ... future of this field. The Asia-Pacific ...
(Date:9/2/2014)... , Sept. 2, 2014 Reportlinker.com announces ... in its catalogue: BRIC Bariatric ... http://www.reportlinker.com/p02343483/BRIC-Bariatric-Surgery-Devices-Market-Outlook-to-2020.html BRIC Bariatric ... Summary GlobalData,s new report, "BRIC ... key market data on the BRIC Bariatric Surgery ...
Breaking Medicine Technology:FDA Tells Congress It Intends to Regulate LDTs! Web Conference to Provide Straight Talk on Essential Steps Clinical Laboratories and Pathology Groups Will Need to Take to Comply 2FDA Tells Congress It Intends to Regulate LDTs! Web Conference to Provide Straight Talk on Essential Steps Clinical Laboratories and Pathology Groups Will Need to Take to Comply 3Asia - Pacific Minimally Invasive Surgery Spinal Device Market 2Asia - Pacific Minimally Invasive Surgery Spinal Device Market 3Asia - Pacific Minimally Invasive Surgery Spinal Device Market 4Asia - Pacific Minimally Invasive Surgery Spinal Device Market 5Asia - Pacific Minimally Invasive Surgery Spinal Device Market 6Asia - Pacific Minimally Invasive Surgery Spinal Device Market 7Asia - Pacific Minimally Invasive Surgery Spinal Device Market 8Asia - Pacific Minimally Invasive Surgery Spinal Device Market 9Asia - Pacific Minimally Invasive Surgery Spinal Device Market 10BRIC Bariatric Surgery Devices Market Outlook to 2020 2BRIC Bariatric Surgery Devices Market Outlook to 2020 3BRIC Bariatric Surgery Devices Market Outlook to 2020 4BRIC Bariatric Surgery Devices Market Outlook to 2020 5BRIC Bariatric Surgery Devices Market Outlook to 2020 6BRIC Bariatric Surgery Devices Market Outlook to 2020 7BRIC Bariatric Surgery Devices Market Outlook to 2020 8BRIC Bariatric Surgery Devices Market Outlook to 2020 9BRIC Bariatric Surgery Devices Market Outlook to 2020 10
... Onyx Pharmaceuticals, Inc. (Nasdaq: ONXX ) announced ... of Directors. Mr. Ringo currently serves as Executive Partner at ... and as a Senior Advisor to Barclays Capital. ... expertise will be invaluable as we look to expand our ...
... CareFusion Corp. (NYSE: CFN ), a leading, ... and six months ended Dec. 31, 2010. "Our ... our Infusion, Dispensing and Infection Prevention businesses, and a benefit ... chairman and CEO, who had announced in November 2010 his ...
Cached Medicine Technology:Onyx Pharmaceuticals Appoints Bill Ringo to Board of Directors 2Onyx Pharmaceuticals Appoints Bill Ringo to Board of Directors 3CareFusion Reports Second Quarter Fiscal 2011 Results 2CareFusion Reports Second Quarter Fiscal 2011 Results 3CareFusion Reports Second Quarter Fiscal 2011 Results 4CareFusion Reports Second Quarter Fiscal 2011 Results 5CareFusion Reports Second Quarter Fiscal 2011 Results 6CareFusion Reports Second Quarter Fiscal 2011 Results 7CareFusion Reports Second Quarter Fiscal 2011 Results 8CareFusion Reports Second Quarter Fiscal 2011 Results 9CareFusion Reports Second Quarter Fiscal 2011 Results 10CareFusion Reports Second Quarter Fiscal 2011 Results 11CareFusion Reports Second Quarter Fiscal 2011 Results 12CareFusion Reports Second Quarter Fiscal 2011 Results 13CareFusion Reports Second Quarter Fiscal 2011 Results 14CareFusion Reports Second Quarter Fiscal 2011 Results 15
(Date:9/2/2014)... September 03, 2014 UWDress.com, an experienced ... has added a lot of fashionable bridesmaid dresses ... the company has launched a special offer to celebrate ... price, from 20 to 60 percent off. , ... to announce our new fashionable bridesmaid dresses for consumers ...
(Date:9/2/2014)... September 03, 2014 Recently, iFitDress.com, a ... occasion gowns, has released its range of 2014 ... now offered at low prices. A large proportion of ... beautiful products from iFitDress.com are carefully made by the ... also offers bachelorette party gowns, ivory satin wedding gowns, ...
(Date:9/2/2014)... 2014 TCG, a leading government technology strategy ... one of the fastest-growing companies in America for the seventh ... was previously recognized in 2013, 2012, 2011, 2010, 2009, 2008, ... grown 86% from 2010 to 2013, ranking the company at ... in America - up 635 spots from 2013! More information ...
(Date:9/2/2014)... On August 30, 2014, Harper’s Bazaar ... You Should Wash Your Face .” According to ... population breathes air considered polluted by the World Health ... the skin’s pores destroying its natural oils. These oils ... that may cause cell damage, redness, aging skin ...
(Date:9/2/2014)... for their own spread throughout the body by coaxing ... according to a new report by Johns Hopkins scientists. ... Nature Communications , the researchers describe animal and cell-culture ... released by breast cancer cells. These molecules cause lymphatic ... to produce proteins called CCL5 and VEGF. CCL5 attracts ...
Breaking Medicine News(10 mins):Health News:Elegant Bridesmaid Dresses For 2014, Latest Designs From UWDress.com 2Health News:Discounted Seashell Wedding Dresses Currently Provided By iFitDress.com 2Health News:TCG One of the Fastest-Growing Companies in America – for the Eighth Time! 2Health News:Simon Ourian, Kim Kardashian’s Doctor: Air Pollution May Be Aging Your Skin 2Health News:‘Prepped’ by tumor cells, lymphatic cells encourage breast cancer cells to spread 2
... rely on outdated data when making ,off-label, decisions, study says ... always have complete or clear information when they prescribe cancer ... for, a new study finds. , According to ... Annals of Internal Medicine , the online and hard-copy ...
... SAN DIEGO, Feb. 17 Tracon Pharmaceuticals, a biotechnology ... diseases, announced today that its three clinical stage cancer ... the 100th Annual Meeting of the American Association for ... "Each program targets a unique pathway with the potential ...
... Upsher-Smith Laboratories,Inc. announced today the publication of results ... estradiol gel 0.1% is an,effective treatment for relief of ... objective of the study was to evaluate the efficacy ... 0.5 mg, and, 0.25 mg/day,including the lowest approved dose ...
... Feb. 17 HotHead Technologies, Inc. today,announced that the ... results by Kennesaw State University researchers as ... "It,s exciting news that research from a ... able to verify much earlier than we anticipated, in,the ...
... 17 Cancer may well surpass cardiovascular,diseases as the ... To prevent this from,happening, cancer therapeutics have to shift ... total cure, despite the complex, multifactorial nature,of cancer indications. ... , "As cancer spreads rapidly ...
... KEEP YOUR PLEDGES BUT DON,T DENY YOUR TASTE BUDS ... ... OAKS, Calif., Feb. 17 /PRNewswire/ -- Creative cooking ... when millions around the world fast and give up their ... lemons are high during the season providing flavor and favor ...
Cached Medicine News:Health News:Doctors' Guide to Cancer Drugs May Need Revising 2Health News:Tracon Pharmaceuticals to Present Clinical Stage Programs at AACR 2009 2Health News:Tracon Pharmaceuticals to Present Clinical Stage Programs at AACR 2009 3Health News:Newly Published Menopause Study: 'Bioidentical' and FDA-Approved Divigel(R) (estradiol gel) 0.1 Percent Safe and Effective Treatment for Moderate to Severe Hot Flashes Associated With Menopause 2Health News:Newly Published Menopause Study: 'Bioidentical' and FDA-Approved Divigel(R) (estradiol gel) 0.1 Percent Safe and Effective Treatment for Moderate to Severe Hot Flashes Associated With Menopause 3Health News:Newly Published Menopause Study: 'Bioidentical' and FDA-Approved Divigel(R) (estradiol gel) 0.1 Percent Safe and Effective Treatment for Moderate to Severe Hot Flashes Associated With Menopause 4Health News:HotHead Technologies' Heat Sensor Shows Exciting Potential by Kennesaw State University Researchers 2Health News:Frost & Sullivan Says, Innovative Therapies Needed to Deal With the Rapid Spread of Cancer in Europe 2Health News:Frost & Sullivan Says, Innovative Therapies Needed to Deal With the Rapid Spread of Cancer in Europe 3Health News:Frost & Sullivan Says, Innovative Therapies Needed to Deal With the Rapid Spread of Cancer in Europe 4Health News:Sunkist(R) Lemons Freshen Up Lenten Foods 2Health News:Sunkist(R) Lemons Freshen Up Lenten Foods 3
... Biventricular Stimulation Device is ... and two ventricular) multi-chamber ... the heart in a ... to promote resynchronization and ...
... system automatically presents diagnostic information ... pacemaker that is easy to ... The automatic Initial Interrogation Report ... clinicians answer their most critical ...
... completely automatic pacemaker, EnPulse offers ... sophisticated yet simple to use. ... of diagnostic tests on a ... This allows more time to ...
The INSIGNIA® pacing systems allow the physician to provide customized adaptive-rate pacing therapy to meet individual patient needs....
Medicine Products: